Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COLOGEN: Genotype-guided Irinotecan/5-FU in mCRC
NCT00138060Phase 4Completed
- Sponsor
- Institut de Recherche Clinique sur les Cancers et le Sang
- Start
- Jun 2005
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of irinotecan in metastatic colorectal cancer (mCRC), sponsored by Institut de Recherche Clinique sur les Cancers et le Sang. Started Jun 2005; status: completed.
02
Drugs
irinotecan
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00138060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00138060.